Barely Significant
← all phrases

“marginally significant”

26,083 sentences · 26,083 papers · 36,483 search hits before verification · confirmed specimen

Sighted at

p>=0.1

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

marginally significantP < 0.12.0× alphagold
Derivation and evaluation of functional groups Classification of woody species We included five traits in the hierarchical agglomerative cluster analysis that were significant ( P ≤ 0.05) or marginally significant ( P < 0.1) for this growth form in perMANOVA testing of either the short‐ or long‐term datasets, including: lifespan, seed size, seed dispersal, height, and leaf longevity.
marginally significantp < 0.12.0× alphagold
Genes were categorized into highly significant ( p < 0.001 and log 2 FC > 2), very significant ( p < 0.01 and log 2 FC > 1.5), significant up ( p < 0.05 and log 2 FC > 1.0), significant down (p < 0.05 and log 2 FC < -1.0), marginally significant ( p < 0.1 ) and not significant ( p ≥ 0.1 ).
marginally significantp = .102.0× alphagold
In a 2 (Time) × 2 (Condition) RM-ANOVA, there was not a significant main effect for Condition, F (1, 30) = 0.52, p = .47, η 2 = .003, but there was a significant main effect for Time, F (1, 30) = 5.18, p = .03, η 2 = .002, and a marginally significant Time by Condition interaction, F (1, 30) = 2.94, p = .10, η 2 = .001.
marginally significantP < 0.12.0× alphagold
Among all 104 tissue and lineage combinations represented by at least three biological replicates, only three combinations showed significantly more species-specific lipid concentration differences than expected by chance (permutations, P < 0.05 at Wilcoxon test P < 0.01 cutoff) and five showed a marginally significant trend (permutations, P < 0.1 at Wilcoxon test P < 0.01 cutoff) ( fig. 3 b ).
Lipidome Evolution in Mammalian Tissues.
Mol Biol Evol · 2018 · PMC6063302
marginally significantP < 0.102.0× alphagold
For hip fracture, patients with no comorbidities experienced significantly lower LOS (− 1.22 days, P < 0.05) and lower FIM score improvement (− 3.69 units, P < 0.05) in expansion states than in non-expansion states after Medicaid expansion, while patients with pre-existing comorbidities experienced a marginally significant increase in LOS (2.43 days, P < 0.10) and no significant changes for functional improvement.